Strychnine as an Emerging Adulterant in the Illicit Fentanyl Drug Supply
AJPM Focus · 2026-10 · 5 (5) · 100410
DOI: 10.1016/j.focus.2025.100410 ↗Kurz gefasst
Fachartikel in der Zeitschrift AJPM Focus, 2026-10. Verfasst von Jennie A Buchanan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Denver Health and Hospital Authority, Denver, Colorado. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse, Intramural Research Program, National Institute on Drug Abuse.
Abstract (Originalsprache)
Awareness of strychnine as an emerging adulterant is extremely important given its unique clinical findings and morbid clinical sequelae. Strychnine was historically utilized as a tonic, laxative, rodenticide, and adulterant in cocaine, heroin, and methamphetamine. This report describes a cluster of patients with acute opioid overdose presenting to an inner-city medical center with strychnine on serum testing. The data for this case series are from the Toxicology Investigator Consortium Fentalog Study, a 2020-2025 study of patients aged ≥18 years evaluated in 10 regionally distinct emergency departments after a suspected opioid overdose. Comprehensive toxicology testing was performed on residual serum samples. Of the 111 cases submitted by all participating sites in January 2023, 4 cases from the Denver, CO site detected strychnine on comprehensive toxicology testing. The total cases from all sites in January 2023 were 921. The presence of strychnine in biological samples of patients utilizing opioids in this report indicates a possible reappearance in its use as an adulterant, warranting further investigation and public preventative health vigilance. Knowledge of local illicit adulterants is crucial for public healthcare providers because it enables them to consider anticipated clinical course and life-saving interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Denver Health and Hospital Authority, Denver, Colorado.
- Rocky Mountain Poison and Drug Safety, Denver, Colorado.
- American College of Medical Toxicology, Phoenix, Arizona.
- Baylor University Medical Center, Dallas, Texas.
- University of California Los Angeles, Los Angeles, California.
- Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania.
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
- Intramural Research Program, National Institute on Drug Abuse
Zitieren
APA
Buchanan, J. A., Lyle, C., Castaneda, M. R., Altholz, J., Ralph, R., Aldy, K., Culbreth, R., Campleman, S., Levine, M., Schwarz, E., Krotulski, A., Wax, P., Brent, J., Manini, A. F., & Toxicology Investigators Consortium Fentalog Study Group (2026). Strychnine as an Emerging Adulterant in the Illicit Fentanyl Drug Supply. AJPM Focus, 5(5), 100410. https://doi.org/10.1016/j.focus.2025.100410
Vancouver
Buchanan JA, Lyle C, Castaneda MR, Altholz J, Ralph R, Aldy K, et al. Strychnine as an Emerging Adulterant in the Illicit Fentanyl Drug Supply. AJPM Focus. 2026;5(5):100410. doi:10.1016/j.focus.2025.100410
BibTeX
@article{Buchanan2026,
author = {Buchanan, Jennie A and Lyle, Carolynn and Castaneda, Marc Retana and Altholz, Jacob and Ralph, Ravikar and Aldy, Kim and Culbreth, Rachel and Campleman, Sharan and Levine, Michael and Schwarz, Evan and Krotulski, Alex and Wax, Paul and Brent, Jeffrey and Manini, Alex F and Toxicology Investigators Consortium Fentalog Study Group, Toxicology Investigators Consortium Fentalog Study Group},
title = {Strychnine as an Emerging Adulterant in the Illicit Fentanyl Drug Supply},
journal = {AJPM Focus},
year = {2026},
volume = {5},
number = {5},
pages = {100410},
doi = {10.1016/j.focus.2025.100410}
}
EUVIMED